Aurobindo Pharma Share Price in Focus; USFDA Inspection at API Subsidiary Concludes with Two Observations

Aurobindo Pharma Limited has informed the stock exchanges that the United States Food and Drug Administration (USFDA) has completed an inspection at Auroactive Pharma Private Limited, its wholly owned subsidiary. 

The inspection concluded with two observations, which the company said will be responded to within the stipulated timeline.  

USFDA Inspects API Manufacturing Facility 

The USFDA conducted the inspection at Auroactive Pharma Private Limited's manufacturing facility in Sancham Village, Ranasthalam Mandal, Srikakulam district, Andhra Pradesh. 

The facility manufactures Active Pharmaceutical Ingredients (APIs) and pharmaceutical formulation intermediates. The inspection was carried out from June 22, 2026, to June 26, 2026.  

Inspection Ends with Two Observations 

According to the company's filing, the inspection concluded with two observations. 

Aurobindo Pharma said it will respond to the observations within the stipulated time.  

No Impact on Financials or Operations 

The company stated that there is no impact on its financials or operations due to the outcome of the inspection. 

It also reiterated its commitment to maintaining the highest quality manufacturing standards and said it would keep the stock exchanges informed of any further developments.  

Read More: Aurobindo Pharma Share Price in Focus; US FDA Classifies Eugia Unit-III as OAI After Inspection! 

Aurobindo Pharma Share Price Performance 

As of 25 June 2026, Aurobindo Pharma share price was closed at ₹1,555.20 per share, reflecting a surge of 1.61% from the previous trading session. 

Conclusion 

Aurobindo Pharma's wholly owned subsidiary, Auroactive Pharma Private Limited, has completed a USFDA inspection that concluded with two observations. The company said it will address the observations within the stipulated timeline and that the inspection has no impact on its financial or operational performance.  

Want to read stock market updates in Hindi? Angel One News gives comprehensive share market news in Hindi. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.